Study objective: To evaluate the short-form 36-item questionnaire as an instrument for measuring health-related quality of life (HRQL) 
Statistical Analysis
Pearson's correlation coefficients (r) were determined to examine the degree of correlation among components of the SF-36, the BDI focal score, and lung function. Multiple linear regression analysis was performed to evaluate the individual contribution of the BDI score and physiologic parameters (independent variables) for the nine components of the SF-36 (dependent variable). '9 Regression coefficients ± SE were obtained from this analysis to indicate the magnitude of the relationship.
A p value of less than 0.05 was considered significant. Values are presented as mean ± SD unless otherwise stated.
RESULTS
Between January and December 1992, 50 patients were recruited into the study. Age was 72 ± 8 years (range, 44 to 84 years), height was 173 ± 6 cm (range, 160 to 185 cm), and weight was 75.6 ± 12.9 kg (range, 52 to 107 kg). Values for the nine components of the SF-36, dyspnea ratings, and physiologic function tests for the group are listed in Table 1 . Based on the FEV1 percent of predicted, 9 patients (18%) had mild disease (>65%), 10 patients (20%) had moderate disease (50 to 64%), and 31 patients (62%) had severe airflow obstruction (<50%). These overall results represent a spectrum of COPD with various levels of dyspnea and HRQL.
The BDI focal score was significantly correlated with FVC as percent predicted (r=0.37; p=0.009), FEV1 as percent predicted (r=0.63; p=0.0001), and Plmax (r=0.56; p=0.0001). Correlations for the components of the SF-36 compared with dyspnea ratings and physiologic function are shown in Table  2 . The BDI score was significantly correlated with seven of the nine components; Plmax and FEV1 as percent predicted were significantly correlated with five components; and FVC as percent predicted was significantly correlated with two components. The relationship between BDI focal score and physical functioning, which exhibited the highest correlation coefficient, for individual subjects is illustrated in Figure 1 .
Regression coefficients obtained from multiple regression analysis for the variables are shown in Table  3 . Multiple regression models showed that the BDI focal score was a significant independent predictor of outcome for seven of the nine components of the SF-36 instrument. In contrast, FVC as percent predicted, FEV1 as percent predicted, and Plmax did not contribute significantly to any of the components of the in asthma" based on significant correlations for most scores of the health components with scores for severity of asthma. The results of our study provide strong evidence for the validity of the SF-36 instrument to measure HRQL in patients with symptomatic COPD. As described by Guyatt and colleagues,2 the validity of a good HRQL instrument depends on correlations between different measures at a point in time consistent with theoretically derived predictions. Thus, we would expect that patients with COPD who report more severe dyspnea and exhibit more impaired lung function would have lower scores for components of HRQL. Correlation coefficients reported in Table 2 demonstrate moderately strong relationships between the BDI focal score and physical functioning, rolephysical, vitality, and general health perceptions, and weaker but statistically significant correlations for social functioning, pain index, and health transition. The correlations for measures of lung function and components of the SF-36 were consistently lower than those observed with the BDI focal score. In addition, regression analysis showed that dyspnea ratings were significant predictors of seven of the nine components of the SF-36. Of the four variables (BDI, FVC, FEVI, and Plmax) included in the regression model, dyspnea was the sole independent measure that contributed to the variability in the majority of the HRQL domains. With exclusion of the BDI focal score as an independent variable, subsequent regression analysis showed that FEV1 (percent predicted) 24 reported good repeatability and sensitivity of the SGRQ in patients with asthma and COPD.
An alternative approach is to select a generic rather than disease-specific instrument to measure HRQL in patients with respiratory disease. The major advantages of a general health profile are as follows: (1) In conclusion, HRQL is an increasingly important consideration for measuring the impact of chronic disease, especially in patients with COPD. Measurement of HRQL provides unique information that is complementary to measures of dyspnea and lung function. Although physiologic variables are helpful to clinicians, most patients are concerned about their symptoms, ability to function, and general wellbeing. Furthermore, health care administrators are particularly interested in HRQL as measures of quality of care and of clinical effectiveness. Although our data support the validity of the SF-36 instrument to measure HRQL in patients with COPD, further studies are required to examine reliability and responsiveness of the SF-36 in this population. We encourage both clinicians and investigators to use available instruments to measure HRQL as an important outcome in caring for and/or evaluating patients with chronic respiratory disease. A diseasespecific instrument, such as the CRQ or the SGRQ, or a generic instrument, such as the Nottingham Health Profile or the SF-36, possibly in combination with a scale to measure a specific symptom, eg, the BDI to grade dyspnea can be used to examine HRQL in patients with respiratory disease.
